Campbell & Co Investment Adviser’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$419K	Sell	25,839 -10,660	-29%	-$189K	0.02%	798
2025 Q4	$683K	Sell	36,499 -16,118	-31%	-$267K	0.03%	712
2025 Q3	$768K	Buy	52,617 +2,225	+4%	+$28.1K	0.06%	531
2025 Q2	$556K	Buy	+50,392	New	+$490K	0.04%	749
2024 Q3	–	Sell	-44,180	Closed	-$375K	–	1322
2024 Q2	$375K	Buy	44,180 +28,678	+185%	+$259K	0.03%	756
2024 Q1	$139K	Buy	+15,502	New	+$144K	0.01%	1045
2022 Q2	–	Sell	-25,100	Closed	-$240K	–	911
2022 Q1	$240K	Buy	+25,100	New	+$246K	0.06%	562
2021 Q4	–	Sell	-27,200	Closed	-$201K	–	815
2021 Q3	$201K	Buy	+27,200	New	+$304K	0.07%	523
2020 Q1	–	Sell	-8,928	Closed	-$231K	–	469
2019 Q4	$231K	Buy	+8,928	New	+$174K	0.07%	527